Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.

Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.

Biotech Health services

Switzerland

Germany

Netherlands

United States

Investments

01 June 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Mosanna Therapeutics (company)

Switzerland

Biotech Health services

Total investments received (USD): 80M

Round value (USD): 80M

Round investors: Broadview Ventures Forbion Capital Partners High-Tech Gründerfonds Norwest Venture Partners Forty51 Ventures Supermoon Capitals Pivotal bioVenture Partners

Company: Mosanna Therapeutics

Industry: Biotech Health services

Related deals

Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital

Biotech Health services Manufacturing Pharma

Switzerland

Germany

France

United Kingdom

Belgium

Italy

Japan

Investments 01 July 2025

ReproNovo raises $65 million in a series A round co-led by AXA IM Alts and M Ventures, joined by Ysios Capital, Jeito and ALSA Ventures

Biotech Health services Pharma Software Services

Spain

Switzerland

France

United Kingdom

Netherlands

Investments 10 May 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top